Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Cancer. 2017 Jul 20;123(22):4449–4457. doi: 10.1002/cncr.30894

Table 1.

Descriptive Statistics of the Sample; Overall and by Race*

Characteristic Overall
N=2374
Non-Hispanic White
N=1907
Non-Hispanic Black
N=394
p-value
Age (years) <.001
 <60 699 (29.4%) 517 (27.1%) 155 (39.3%)
 60–64 508 (21.4%) 401 (21.0%) 89 (22.6%)
 65–69 558 (23.5%) 472 (24.8%) 72 (18.3%)
 70–74 347 (14.6%) 288 (15.1%) 48 (12.2%)
 ≥75 262 (11.0%) 229 (12.0%) 30 (7.6%)

Insurance <.001
 Private 1309 (55.1%) 1070 (56.1%) 205 (52.0%)
 Medicaid 72 (3.0%) 23 (1.2%) 42 (10.7%)
 Medicare 956 (40.3%) 787 (41.3%) 138 (35.0%)

Income <.001
 <$25,000 306 (12.9%) 130 (6.8%) 152 (38.6%)
 $25,000–49,999 389 (16.4%) 306 (16.1%) 76 (19.3%)
 $50,000–74,999 365 (15.4%) 309 (16.2%) 44 (11.2%)
 $75,000–99,999 313 (13.2%) 261 (13.7%) 45 (11.4%)
 ≥$100,000 740 (31.2%) 691 (36.2%) 37 (9.4%)

Education <.001
 Some high school 176 (7.4%) 91 (4.8%) 68 (17.3%)
 High school grad/GED 588 (24.8%) 437 (22.9%) 134 (34.0%)
 Some college/2-year degree 509 (21.4%) 390 (20.5%) 101 (25.6%)
 4-year college grad 381 (16.1%) 336 (17.6%) 37 (9.4%)
 >4-year college degree 665 (28.0%) 609 (31.9%) 45 (11.4%)

Marital Status <.001
 Married 1895 (79.8%) 1603 (84.1%) 232 (58.9%)
 Not married 444 (18.7%) 282 (14.8%) 149 (37.8%)

Life Expectancy <.001
 <25% mortality 739 (31.1%) 606 (31.8%) 110 (27.9%)
 25–50% mortality 743 (31.3%) 639 (33.5%) 85 (21.6%)
 50–75% mortality 532 (22.4%) 409 (21.5%) 108 (27.4%)
 >75% mortality 216 (9.1%) 154 (8.1%) 52 (13.2%)

Gleason Score 0.02
 <7 940 (39.6%) 776 (40.7%) 131 (33.3%)
 7 946 (39.9%) 741 (38.9%) 175 (44.4%)
 >7 413 (17.4%) 331 (17.4%) 73 (18.5%)

AJCC clinical tumor stage 0.10
 Stage 1 1695 (71.4%) 1346 (70.6%) 294 (74.6%)
 Stage 2 573 (24.1%) 477 (25.0%) 79 (20.1%)
 Stage 3 58 (2.4%) 45 (2.4%) 12 (3.1%)

Receipt of Definitive Treatment 0.09
 Yes 2028 (85.4%) 1639 (90.0%) 330 (83.8%)
 No 295 (12.4%) 224 (11.8%) 59 (15.0%)

Radical Prostatectomy 0.40
 Yes 1223 (51.5%) 992 (52.0%) 192 (49.8%)
 No 1053 (44.4%) 838 (43.9%) 182 (46.2%)

Communication <.001
 Good 1631 (68.7%) 1346 (70.6%) 237 (60.2%)
 Not Good 718 (30.2%) 542 (28.4%) 152 (38.6%)

Perceived Quality <.001
 Good 1860 (78.4%) 1538 (80.7%) 270 (68.5%)
 Not Good 438 (18.5%) 310 (16.3%) 111 (28.2%)

Abbreviation: GED, General Educational Development; AJCC, American Joint Committee on Cancer

*

Race stratified columns exclude 73 men of Hispanic ethnicity or not white or black race.

Certain characteristics do not add up to 100% due to missing data.